Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Understand the source comparison

Best Peptides for Emotional Eating: Research Comparison

Semaglutide GLP-1 receptor agonist. Slows gastric emptying, extends satiety signaling 90–120 min post-meal Strong (Phase 3 RCTs, FDA-approved for weight management) 0.25–2.4mg weekly subcutaneous Emotional eating driven by rapid ghrelin rebound post-meal Best-

No winner is assigned.

This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.

  • Semaglutide
  • GLP-1 receptor agonist. Slows gastric emptying, extends satiety signaling 90–120 min post-meal
  • Strong (Phase 3 RCTs, FDA-approved for weight management)
  • 0.25–2.4mg weekly subcutaneous
  • Emotional eating driven by rapid ghrelin rebound post-meal
  • Best-supported peptide for emotional eating. Directly targets satiety pathways disrupted by stress
  • Tirzepatide
  • Dual GLP-1/GIP receptor agonist. Combines satiety extension with insulin sensitivity improvement
  • Strong (Phase 3 RCTs, FDA-approved)
  • 2.5–15mg weekly subcutaneous
  • Emotional eating with insulin resistance or metabolic syndrome
  • Strongest weight loss data; dual mechanism addresses both hunger and metabolic dysfunction
  • MK-677
  • Ghrelin receptor agonist. Increases GH/IGF-1, may desensitize ghrelin receptors long-term
  • Moderate (Phase 2 data, not approved for appetite)
  • 10–25mg daily oral
  • Research into ghrelin receptor dynamics. Not acute appetite suppression
  • Increases hunger acutely; research use only for receptor desensitization studies
  • Hexarelin
  • Growth hormone secretagogue with CRH modulation in preclinical models
  • Weak (animal models only for stress-eating)
  • 100–200mcg twice daily subcutaneous
  • Stress-driven eating via hypothalamic cortisol pathways
  • Promising mechanism but lacks human emotional eating data
  • Cerebrolysin
  • Neurotrophic peptide. Promotes neuroplasticity and emotional regulation
  • Moderate (human trials for cognitive function, not eating behavior)
  • 10–30mL IV over 10–20 sessions
  • Cognitive retraining for prefrontal override of limbic hunger
  • Indirect mechanism. Improves executive control rather than appetite signaling